20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T67755 | Protein kinase G inhibitor-1 | PKA | |
Protein kinase G inhibitor-1 is a potent Protein kinase G inhibitor, IC50= 0.9 uM. | |||
T9940 | Protein kinase G inhibitor-2 | Others | |
Protein kinase G inhibitor-2 exhibits antibacterial, antiviral, and antitumor activities. | |||
TP1902L1 | G-Protein antagonist peptide acetate | Adrenergic Receptor | |
G-Protein antagonist peptide acetate is a truncated substance P-related peptide, competes with receptor for G protein binding. G-Protein antagonist peptide acetate inhibits the activation of Gi or Go by M2 muscarinic cho... | |||
TP1902 | G-Protein antagonist peptide | ||
Substance P-related peptide that inhibits binding of G proteins to their receptors. Competitively and reversibly inhibits M2 muscarinic receptor activation of Gi or Go and inhibits Gs activation by β-adrenoceptors. | |||
T14898 | CCG-63808 | GTPase | |
CCG-63808 is a reversible inhibitor of regulator of G-protein signaling (RGS) proteins. CCG-63808 dose-dependently inhibits the TR-FRET signal between RGS4-AF488 and Tb-Gαo with IC50 values of 1.9 μM. | |||
TP2254 | GTP-Binding Protein Fragment, G alpha | Others | |
Using specific antisera raised against synthetic peptides, we find that three distinct GTP-binding protein alpha subunits remain bound to the plasma membrane even after activation with nonhydrolyzable GTP analog. Trypsin... | |||
T14897 | CCG-63802 | GTPase | |
CCG-63802 is a reversible inhibitor of the regulator of G-protein signaling (RGS) protein and has the greatest potency at RGS4. | |||
T8818 | TC-G 1005 | GPCR19 | |
TC-G 1005 is a potent and selective GPBA agonist (EC50 :0.72 nM; hTGR5). Selective for TGR5 over FXR (farnesoid X receptor). Increases plasma GLP-1 levels and reduces blood glucose in mice. Orally available. | |||
T6512 | G-418 disulfate | Geneticin,G418 Sulfate,Antibiotic G-418 sulfate,Geneticin sulfate | Antibacterial , Antibiotic |
G-418 disulfate (Geneticin sulfate) is an aminoglycoside antibiotic, an inhibitor of protein synthesis with eukaryotic selectivity. G-418 disulfate blocks peptide synthesis by inhibiting peptide chain elongation. | |||
T7428 | SBI-115 | GPCR19 | |
SBI-115 is an antagonist of TGR5. SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5 | |||
T4083 | BAR501 | BAR 501 | GPCR19 |
BAR501 is an effective and specific GPBAR1 agonist (EC50: 1 μM). | |||
TQ0252 | BAR502 | FXR , GPCR19 , Autophagy | |
BAR502 is a dual GPBAR1 and FXR agonist (IC50s: 0.4 μM and 2 μM). | |||
T20731 | Brilliant blue G-250 | BBG,Acid blue 90, Coomassie Brilliant Blue G,Brilliant Blue G | P2X Receptor |
Brilliant blue G-250 (Acid blue 90, Coomassie Brilliant Blue G) is an antagonist of the P2X7 purinergic receptor. | |||
T4352 | SB756050 | SB-756050,SB 756050 | GPCR19 |
SB756050 is a specific TGR5 agonist. | |||
T2088 | APD668 | APD 668 | GPR , P450 , Potassium Channel |
APD668 is a potent GPR119 agonist with EC50 of 2.7 nM and 33 nM for hGPR119 and ratGPR119, respectively. | |||
T5077 | Deoxycholic acid sodium salt | Sodium deoxycholate,Sodium Desoxycholate | Endogenous Metabolite , GPCR19 |
Deoxycholic acid sodium salt (Sodium deoxycholate) can activate the G protein-coupled bile acid receptor TGR5 that stimulates brown adipose tissue (BAT) thermogenic activity. | |||
TN2268 | Tetrahydromagnolol | Cannabinoid Receptor , GPR , GABA Receptor | |
Tetrahydromagnolol can activate cannabinoid (CB) receptors. | |||
T2965 | Deoxycholic acid | Cholorebic,Deoxycholate,Desoxycholic acid,Cholanoic Acid,Cholerebic | Endogenous Metabolite , GPCR19 |
Deoxycholic acid (Cholanoic Acid) is a bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorptio... | |||
T6434 | CCG-50014 | CCG 50014 | GTPase |
CCG-50014 is a potent and selective inhibitor of RGS4 with IC50 of 30 nM. | |||
T16378 | Ogerin | Others , 5-HT Receptor , Adenosine Receptor | |
Ogerin is a selective GPR68 positive allosteric modulator (pEC50: 6.83). Ogerin blocks recall in fear conditioning in mice. Ogerin displays inverse agonist and antagonist activity (Ki, 220 nM) at A2A receptor and weak an... |